Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome
US7501511B2 · kind B2 · utility
8Cited by
1References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 2004 |
| Grant date | Mar 10, 2009 |
| Priority date | — |
| Expiry date | Oct 28, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed towards a process for resolving a racemic amino compound derived from dihydro-1,3,5-triazines. The invention is also directed towards the enantiomers of amino derivatives of dihydro-1,3,5-triazines and to their use for the preparation of medicaments, in particular for the treatment of diabetes and malaria.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.